Pfizer

News

GSK consumer health spin-off Haleon starts trading

GSK's consumer health spinout Haleon started trading on the London Stock Exchange this morning, making its debut with a price of 330 pence and a market valuation of around £31 billion ($37

News

FDA clears Xalkori for inflammatory myofibroblastic tumours

Pfizer's tyrosine kinase inhibitor Xalkori has picked up a fourth approval from the FDA, adding a new use in the treatment of a rare form of benign tumour that typically affects children an

News

EU watchdog formally reprimands Commission over Pfizer texts

The European Commission's failure to reveal text messages between president Ursula von der Leyen and Pfizer chief executive Albert Bourla on COVID-19 vaccine procurement has earned it a for

News

ResApp bags FDA okay for sleep apnoea app, after Pfizer take...

Pfizer is still waiting for the green light to complete an acquisition of digital health company ResApp, a deal that looks even better now that its smartphone app for people with obstructiv

News

FDA backs pharmacist prescribing of Paxlovid for COVID

Some patients with COVID-19 will be able to get easier access to Pfizer's oral antiviral therapy Paxlovid, after the FDA ruled that pharmacists would be able to prescribe the drug.

News

Myocarditis case mars Sarepta DMD gene therapy readout

New data on Sarepta's gene therapy for Duchenne muscular dystrophy (DMD) has gone a long way towards building confidence in its efficacy – but have introduced a concern about its safety.

GSK consumer health spin-off Haleon starts trading

FDA clears Xalkori for inflammatory myofibroblastic tumours

EU watchdog formally reprimands Commission over Pfizer texts

ResApp bags FDA okay for sleep apnoea app, after Pfizer take...

FDA backs pharmacist prescribing of Paxlovid for COVID

Myocarditis case mars Sarepta DMD gene therapy readout

Biotech is back, with Craig Ackerman

Using AI-driven synthetic personas to take your insights fur...

Pfizer

Editor's Picks